DigniCap Scalp Cooling System
Prevention of Chemotherapy-Induced Alopecia
ApprovedActive
Key Facts
About DIGNITANA
Dignitana is a commercial-stage medical device company focused on oncology supportive care through its flagship product, the DigniCap Scalp Cooling System. Having received the first FDA clearance for scalp cooling in the U.S. in 2015, the company has established a significant position in a growing niche market aimed at mitigating a distressing side effect of chemotherapy. In 2025, the company entered into a definitive agreement to be acquired by the Paxman Group, a move that will lead to its delisting from Nasdaq First North. This acquisition consolidates two leading players in the scalp cooling space, creating a combined entity with broader global reach and product offerings.
View full company profile